Developmental Function in Toddlers With Sickle Cell Anemia

被引:45
作者
Armstrong, F. Daniel [1 ,2 ]
Elkin, T. David [3 ]
Brown, R. Clark [4 ]
Glass, Penny [5 ]
Rana, Sohail [6 ]
Casella, James F. [7 ]
Kalpatthi, Ram V. [8 ]
Pavlakis, Steven [9 ]
Mi, Zhibao [10 ]
Wang, Winfred C. [11 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA
[2] Univ Miami, Jackson Mem Med Ctr, Holtz Childrens Hosp, Miami, FL USA
[3] Univ Mississippi, Sch Med, Dept Psychiat & Human Behav, Jackson, MS 39216 USA
[4] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA
[5] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA
[6] Howard Univ, Coll Med, Dept Pediat, Washington, DC USA
[7] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[8] Childrens Mercy Hosp & Clin, Dept Pediat, Kansas City, MO USA
[9] Mt Sinai Sch Med, Dept Pediat, New York, NY USA
[10] Clin Trials & Surveys Corp, Owings Mills, MD USA
[11] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA
基金
美国国家卫生研究院;
关键词
sickle cell disease; cognitive development; transcranial Doppler; Bayley Scales; toddlers; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; TRIAL BABY HUG; YOUNG-CHILDREN; RISK-FACTORS; DISEASE; ABNORMALITIES; TRANSFUSION; HYDROXYUREA; MULTICENTER; DYSFUNCTION;
D O I
10.1542/peds.2012-0283
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
BACKGROUND: Neurocognitive impairment occurs in children and adults with sickle cell anemia, but little is known about neurodevelopment in very young children. We examined the neurodevelopmental status of infants participating in the Pediatric Hydroxyurea Phase III Clinical Trial (Baby Hug) to determine relationships with age, cerebral blood flow velocity, and hemoglobin concentration. METHODS: Standardized measures of infant neurodevelopment were administered to 193 infants with hemoglobin SS or hemoglobin S-beta(0) thalassemia between 7 and 18 months of age at the time of their baseline evaluation. Associations between neurodevelopmental scores and age, family income, parent education, hemoglobin concentration, and transcranial Doppler velocity were examined. RESULTS: Mean functioning on the baseline neurodevelopment scales was in the average range. There were no mental development scores <70 (impaired); 22 children had scores in the clinically significant range, 11 with impaired psychomotor scores and 11 with problematic behavior rating scores. Significantly poorer performance was observed with older age at baseline. Behavior rating scores were an average of 2.82 percentile points lower per month of age, with similar patterns observed with parent report using adaptive behavior scales. Parent-reported functional abilities and hemoglobin were negatively associated with higher transcranial Doppler velocities. CONCLUSIONS: Whereas overall functioning was in the normal range, behavioral and adaptive function was poorer with older age, even in this very young group of children. Explanatory mechanisms for this association between poorer developmental function and older age need to be identified. Pediatrics 2013;131:e406-e414
引用
收藏
页码:E406 / E414
页数:9
相关论文
共 23 条
[1]   Neurodevelopment and chronic illness: Mechanisms of disease and treatment [J].
Armstrong, F. Daniel .
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2006, 12 (03) :168-173
[2]  
Armstrong FD, 1996, PEDIATRICS, V97, P864
[3]   Multicenter prospective study of children with sickle cell disease:: Radiographic and psychometric correlation [J].
Bernaudin, F ;
Verlhac, S ;
Fréard, F ;
Roudot-Thoravel, F ;
Benkerrou, M ;
Thuret, I ;
Mardini, R ;
Vannier, JP ;
Ploix, E ;
Romero, M ;
Cassé-Perrot, C ;
Helly, M ;
Gillard, E ;
Sebag, G ;
Kchouk, H ;
Pracros, JP ;
Finck, B ;
Dacher, JN ;
Ickowicz, V ;
Raybaud, C ;
Poncet, M ;
Lesprit, E ;
Reinert, PH ;
Brugières, P .
JOURNAL OF CHILD NEUROLOGY, 2000, 15 (05) :333-343
[4]   DESIGN OF THE SILENT CEREBRAL INFARCT TRANSFUSION (SIT) TRIAL [J].
Casella, James F. ;
King, Allison A. ;
Barton, Bruce ;
White, Desiree A. ;
Noetzel, Michael J. ;
Ichord, Rebecca N. ;
Terrill, Cindy ;
Hirtz, Deborah ;
McKinstry, Robert C. ;
Strouse, John J. ;
Howard, Thomas H. ;
Coates, Thomas D. ;
Minniti, Caterina P. ;
Campbell, Andrew D. ;
Vendt, Bruce A. ;
Lehmann, Harold ;
DeBaun, Michael R. .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2010, 27 (02) :69-89
[5]   Cognitive screening examinations for silent cerebral infarcts in sickle cell disease [J].
DeBaun, MR ;
Schatz, J ;
Siegel, MJ ;
Koby, M ;
Craft, S ;
Resar, L ;
Chu, JY ;
Launius, G ;
Dadash-Zadeh, M ;
Lee, RB ;
Noetzel, M .
NEUROLOGY, 1998, 50 (06) :1678-1682
[6]  
Gladwin MT, 2006, ADV EXP MED BIOL, V588, P189
[7]   Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease [J].
Gladwin, MT ;
Shelhamer, JH ;
Ognibene, FP ;
Pease-Fye, ME ;
Nichols, JS ;
Link, B ;
Patel, DB ;
Jankowski, MA ;
Pannell, LK ;
Schechter, AN ;
Rodgers, GP .
BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (02) :436-444
[8]   Detection and assessment of stroke in patients with sickle cell disease: Neuropsychological functioning and magnetic resonance imaging [J].
Gold, Jeffrey I. ;
Johnson, Caroline B. ;
Treadwell, Marsha J. ;
Hans, Nitu ;
Vichinsky, Elliott .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2008, 25 (05) :409-421
[9]   Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypes [J].
Kato, Gregory J. ;
Gladwin, Mark T. ;
Steinberg, Martin H. .
BLOOD REVIEWS, 2007, 21 (01) :37-47
[10]   Transcranial Doppler ultrasonography and executive dysfunction in children with sickle cell disease [J].
Kral, MC ;
Brown, RT .
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2004, 29 (03) :185-195